Search Results - "Jacobs, LD"

Ketoprofen, paracetamol and placebo in the treatment of episodic tension-type headache by Dahlöf, C G, Jacobs, L D

“…The aim of the study was to assess the efficacy and tolerability of a single oral dose of ketoprofen 25 mg in comparison with single doses of ketoprofen 2 x 25…”
Get more information

Rapid online quantification of left ventricular volume from real-time three-dimensional echocardiographic data by Jacobs, Lawrence D., Salgo, Ivan S., Goonewardena, Sascha, Weinert, Lynn, Coon, Patrick, Bardo, Dianna, Gerard, Olivier, Allain, Pascal, Zamorano, Jose L., de Isla, Leopoldo P., Mor-Avi, Victor, Lang, Roberto M.

“…Aims Determination of left ventricular (LV) volumes and ejection fraction (EF) from two-dimensional echocardiographic (2DE) images is subjective,…”
Get full text

Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis by Jacobs, Lawrence D, Beck, Roy W, Simon, Jack H, Kinkel, R. Phillip, Brownscheidle, Carol M, Murray, Thomas J, Simonian, Nancy A, Slasor, Peter J, Sandrock, Alfred W

“…Multiple sclerosis is a chronic, inflammatory, demyelinating disease of the central nervous system that most commonly affects women, with an onset typically…”
Get full text

A longitudinal study of brain atrophy in relapsing multiple sclerosis by SIMON, J. H, JACOBS, L. D, SIMONIAN, N, LAJAUNIE, M, MILLER, D. E, WENDE, K, MARTENS-DAVIDSON, A, KINKEL, R. P, MUNSCHAUER, F. E, BROWNSCHEIDLE, C. M, CAMPION, M. K, RUDICK, R. A, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GOODKIN, D. E

Get full text

Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses by Beck, Roy W, Chandler, Danielle L, Cole, Stephen R, Simon, Jack H, Jacobs, Lawrence D, Kinkel, R Philip, Selhorst, John B, Rose, John W, Cooper, Joanna A, Rice, George, Murray, Thomas J, Sandrock, Alfred W

“…The objective of this work was to assess the effect of interferon beta-1a (Avonex) on the rate of development of clinically definite multiple sclerosis and…”
Get full text

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis by RUDICK, R. A, SIMONIAN, N. A, MASS, M. K, RICHERT, J. R, SALAZAR, A. M, MUNSCHBAUER, F. E, COOKFAIR, D. L, SIMON, J. H, JACOBS, L. D, ALAM, J. A, CAMPION, M, SCARAMUCCI, J. O, JONES, W, COATS, M. E, GOODKIN, D. E, WEINSTOCK-GUTTMAN, B, HERNDON, R. M

Get full text

Imaging and Quantification of Myocardial Perfusion Using Real-Time Three-Dimensional Echocardiography by Toledo, Eran, Lang, Roberto M., Collins, Keith A., Lammertin, Georgeanne, Williams, Ursula, Weinert, Lynn, Bolotin, Gil, Coon, Patrick D., Raman, Jai, Jacobs, Lawrence D., Mor-Avi, Victor

“…Imaging and Quantification of Myocardial Perfusion Using Real-Time Three-Dimensional Echocardiography Eran Toledo, Roberto M. Lang, Keith A. Collins,…”
Get full text

Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients by Nguyen, Linh T., Ramanathan, Murali, Weinstock-Guttman, Bianca, Baier, Monika, Brownscheidle, Carol, Jacobs, Lawrence D.

“…We compared the patterns of the pro-inflammatory cytokines, interferon-γ (IFN-γ), interleukin-2 (IL-2) and tumor necrosis factor-α (TNF-α), and the…”
Get full text

Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium by WEINSTOCK-GUTTMAN, B, JACOBS, L. D, GOTTESMAN, M. H, HERBERT, J, HOLUB, R, LAVA, N. S, LENIHAN, M, LUSINS, J, MIHAI, C, MILLER, A. E, PEREL, A. B, SNYDER, D. H, BROWNSCHEIDLE, C. M, BAKSHI, R, GRANGER, C. V, GREENBERG, S. J, JUBELT, B, KRUPP, L, MUNSCHAUER, F. E, RUBIN, D, SCHWID, S, SMIROLDO, J, BAIER, M, REA, D. F, APATOFF, B. R, BLITZ, K. M, COYLE, P. K, FRONTERA, A. T, GOODMAN, A. D

“…The objective of this study was to determine the clinical characteristics of multiple sclerosis (MS) in African American (AA) patients in the New York State…”
Get full text

What is new in the treatment of multiple sclerosis? by WEINSTOCK-GUTTMAN, B, JACOBS, L. D

“…Multiple sclerosis (MS) is considered an autoimmune disease associated with immune activity directed against central nervous system antigens. Based on this…”
Get full text

Effectiveness of Echocardiographic Imaging by Nurses to Identify Left Ventricular Systolic Dysfunction in High-Risk Patients by Kirkpatrick, James N., Belka, Vicki, Furlong, Kathy, Balasia, Beth, Jacobs, Larry D., Corcoran, Matt, Anderson, Allen S., Pastoret, Anne, Spencer, Kirk T.

“…Recognizing left ventricular (LV) systolic dysfunction is critical. The investigators sought to evaluate whether nurses could be trained to use a hand-carried…”
Get full text

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis by RUDICK, R. A, GOODKIN, D. E, ALAM, J. J, SIMONIAN, N. A, CAMPION, M. K, BARTOSZAK, D. M, BOURDETTE, D. N, BRAIMAN, J, BROWNSCHEIDLE, C. M, COATS, M. E, COHAN, S. L, DOUGHERTY, D. S, JACOBS, L. D, KINKEL, R. P, MASS, M. K, MUNSCHAUER, F. E, PRIORE, R. L, PULLICINO, P. M, SCHEROKMAN, B. J, WEISTOCK-GUTTMAN, B, WHITHAM, R. H, COOKFAIR, D. L, HERNDON, R. M, RICHERT, J. R, SALAZAR, A. M, FISCHER, J. S, GRANGER, C. V, SIMON, J. H

Get full text

Pharmacokinetics of Articaine Hydrochloride in Tumescent Local Anesthesia for Liposuction by Grossmann, Matthias, Sattler, Gerhard, Pistner, Hans, Oertel, Reinhard, Richter, Klaus, Schinzel, Stefan, Jacobs, Laurent-Didier

“…The aim of the investigation was to assess the pharmacokinetic characteristics and safety of articaine HCl used in tumescent local anesthesia for liposuction…”
Get full text

Intra-articular absorption and distribution of ketoprofen after topical plaster application and oral intake in 100 patients undergoing knee arthroscopy by ROLF, C, ENGSTRÖM, B, BEAUCHARD, C, JACOBS, L. D, LE LIBOUX, A

“…The primary objective of this study was to assess the kinetics of ketoprofen in synovial fluid and intra-articular tissues in relation to plasma. The secondary…”
Get full text

A profile of multiple sclerosis: The New York State Multiple Sclerosis Consortium by Jacobs, L D, Wende, K E, Brownscheidle, C M, Apatoff, B, Coyle, P K, Goodman, A, Gottesman, M H, Granger, C V, Greenberg, S J, Herbert, J, Krupp, L, Lava, N S, Mihai, C, Miller, A E, Perel, A, Smith, C R, Snyder, D H

“…We have obtained a current profile of multiple sclerosis (MS) in New York State through a centralized patient registry and standardized data collection…”
Get full text

Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis by Jacobs, L D, Kaba, S E, Miller, C M, Priore, R L, Brownscheidle, C M

“…We found 42 of 74 patients (57%) with isolated monosymptomatic optic neuritis to have 1 to 20 brain lesions, by magnetic resonance imaging (MRI). All of the…”
Get more information

Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis by Rudick, Richard A., Cookfair, Diane L., Simonian, Nancy A., Ransohoff, Richard M., Richert, John R., Jacobs, Lawrence D., Herndon, Robert M., Salazar, Andres M., Fischer, Jill S., Granger, Carl V., Goodkin, Donald E., Simon, Jack H., Bartoszak, David M., Bourdette, Dennis N., Braiman, Jonathan, Brownscheidle, Carol M., Coats, Michael E., Cohan, Stanley L., Dougherty, David S., Kinkel, Revere P., Mass, Michele K., Munchsauer, Frederick E., O'Reilly, Kathy, Priore, Roger L., Pullicino, Patrick M., Scherokman, Barbara J., Wende, Karl, Weinstock-Guttman, Bianca, Whitham, Ruth H.

“…Background and objective: This report provides results of CSF analyses done in a subset of relapsing remitting MS patients participating in a…”
Get full text

Improved glycemic control with decreased hypoglycemia prevents long-term complications in type 2 diabetes patients: long-term simulation analysis using the "diabetes mellitus model" by Maxion-Bergemann, S, Huppertz, E, Jacobs, L D, Müller, E, Walleser, S

“…The purpose of this study was to compare the effect of insulin glargine (glargine) and NPH insulin (NPH) on long-term outcomes in type 2 diabetes patients…”
Get full text

Are quantitative functional measures more sensitive to worsening MS than traditional measures? by SCHWID, S. R, GOODMAN, A. D, APATOFF, B. R, COYLE, P. K, JACOBS, L. D, KRUPP, L. B, MILLER, A. E, WENDE, K. E, BROWNSCHEIDLE, C. M

“…The authors used data collected prospectively during a multicenter trial in 133 patients with secondary progressive MS to assess the relative sensitivity of…”
Get full text

Detection of Cytochrome P450 and Other Drug-Metabolizing Enzyme mRNAs in Peripheral Blood Mononuclear Cells Using DNA Arrays by NGUYEN, L. T, RAMANATHAN, M, WEINSTOCK-GUTTMAN, B, DOLE, K, MILLER, C, PLANTER, M, PATRICK, K, BROWNSCHEIDLE, C, JACOBS, L. D

“…The purpose of this study was to determine whether the expression of cytochrome P450 (CYP) enzyme mRNAs, other drug-metabolizing enzyme mRNAs, and transporter…”
Get full text